Toggle navigation
Home
Search
Services
Blog
Contact
About
Suppositories for Rapid Anti-Epileptic Diazepam Delivery
Nuwayser, E S.
Biotek, Inc., Woburn, MA, United States
Search 84 grants from E Nuwayser
Search grants from Biotek, Inc.
Share this grant:
:
:
Abstract
Funding
Institution
Related projects
Comments
Recent in Grantomics:
Massachusetts Institute of Technology
vs. funders. Who wins?
Read more...
How should you pick the next fundable research topic?
Read more...
Recently viewed grants:
Control of Dendritic and Synaptic Development by Extracellular Cues
GPCR Kinase-2 in TNFalpha Signaling in Macrophages
Hereditary Breast Cancer: Genetic and Molecular Studies
Gene Somatic Mutations and Autoantibody Specificities
Brain Tumor Cooperative Group - CNS Tumor Biology Therapy
Recently added grants:
Bridging diffusion MRI and chemical tracing for validation and inference of fiber architectures
A hybrid effectiveness-implementation trial of a school based executive function treatment for transition age youth with autism
Multiscale Modeling of Right Ventricular Fibrotic Remodeling in Pulmonary Arterial Hypertension
Mechanisms of non-centrosomal microtubule-organizing center functions
Noninvasive transcranial detection of intracranial hemorrhage using a tri-coil handheld portable eddy current damping imaging device
Abstract
Funding Agency
Agency
National Institute of Health (NIH)
Institute
National Institute of Neurological Disorders and Stroke (NINDS)
Type
Small Business Innovation Research – Phase I (N43)
Project #
N43NS012310-001
Application #
3668753
Study Section
Project Start
1991-06-30
Project End
Budget Start
1991-12-18
Budget End
1992-03-31
Support Year
Fiscal Year
1992
Total Cost
Indirect Cost
Institution
Name
Biotek, Inc.
Department
Type
DUNS #
City
Woburn
State
MA
Country
United States
Zip Code
01801
Related projects
NIH 1992
N43 NS
Suppositories for Rapid Anti-Epileptic Diazepam Delivery
Nuwayser, E S. / Biotek, Inc.
NIH 1991
N43 NS
Suppositories for Rapid Anti-Epileptic Diazepam Delivery
Nuwayser, E S. / Biotek, Inc.
Comments
Be the first to comment on this grant